1. The Patient With Early Stage MF-CTCL

3. MF: Progression

4. Staging

5. MF/SS: Disease-Specific Survival in 1502 Patients

6. Cutaneous Lymphoma Treatments

7. Current Treatment Recommendations

8. Low-Dose TSEB in Patients With MF: UK Cutaneous Lymphoma Group

9. Targeted Therapy in CTCL

10. Stage-Dependent Treatment

11. Mechlorethamine*

12. Phototherapy: UVB and PUVA

13. Stage-Dependent Treatment

14. Adverse Event Management: Best Practices

15. Including the Patient's Perspective on Choice of Therapy

16. Key Issues for Treatment of MF

17. Concluding Remarks

18. Abbreviations